Healthtree, Inc.
Records under this name other than the patents Healthtree, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.
Showing 1 to 3 of 3 · Back to Healthtree, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,840,881 | Methods and Compositions for Treating Prostate Cancer or Inducing a Humoral Immune Response Against Prostate Cancer Lapsed on the fee record Ended Sep 23, 2026 · High confidence | Lapsed on the fee record | Ended Sep 23, 2026 | High confidence |
| US 7,176,022 | Directly injectable formulations which provide enhanced cryoprotection of cell products Term ended Term ended Feb 27, 2024 · USPTO record | Term ended | Term ended Feb 27, 2024 | USPTO record |
| US 9,848,598 | Cryoprotected, frozen recombinant cancer cells Term ended Ended no later than Dec 20, 2022 · USPTO record | Term ended | Ended no later than Dec 20, 2022 | USPTO record |